Clinical Trials
1
Active:0
Completed:1
Trial Phases
1 Phases
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 2
1 (100.0%)Study to Assess Safety and Impact of SelG1 With or Without Hydroxyurea Therapy in Sickle Cell Disease Patients With Pain Crises
- First Posted Date
- 2013-07-10
- Last Posted Date
- 2020-01-31
- Lead Sponsor
- Reprixys Pharmaceutical Corporation
- Target Recruit Count
- 198
- Registration Number
- NCT01895361
News
No news found